In Finland, a country of 5.6 million people, everyone seemed to know someone who had their therapy records stolen. It became ...

BridgeBio Pharma, Inc. recently announced a US$550,000,000 fixed-rate senior subordinated unsecured notes offering under Rule ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. From facial ...

Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...

Therapy doesn’t end at the session door. Real growth happens between appointments, as you practice skills, reflect on ...

ProKidney Corp., a clinical-stage biotechnology company based in North Carolina, is developing a first-in-class cell therapy ...

Despite 700% net product revenue growth to $113 million, ImmunityBio's high debt load and unprofitability remain significant ...

Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to ...

Word spread through running clubs and gym communities about a clinic where therapists didn't just knead muscles but conducted ...

NEW YORK and SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- Ouroboros Family Founders Fund I, LP announced this week it will lead a $60 million Series A financing in Cytotheryx, Inc., a preclinical cell ...

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...

While resistance is a natural evolutionary process, the review shows that human activity has dramatically intensified its ...